Back to Results
First PageMeta Content
Clinical research / Critical Path Institute / Drug discovery / Pharmaceutical industry / Biomarker / Food and Drug Administration / Medicine / Pharmacology / Pharmaceutical sciences


CRITICAL PATH INSTITUTE (C-PATH) & INNOVATIVE MEDICINES INITIATIVE (IMI) 2ND ANNUAL MEETING ACCELERATING THE DEVELOPMENT OF DRUGS, DIAGNOSTICS, AND DEVICES: PARTNERSHIPS TO EXPAND THE PRECOMPETITIVE SPACE
Add to Reading List

Document Date: 2014-12-11 10:11:33

Open Document

File Size: 2,30 MB

Share Result on Facebook

City

Faster Evidence / DILI / DIVI / /

Company

Pfizer / Biobank / Merck / Collaborators Consortia Members (19) Partners / Sanofi / /

Facility

CRITICAL PATH INSTITUTE / /

MedicalCondition

drug-induced injuries / vascular injury / diseases / liver failure / drug-induced vascular injury / /

Organization

FDA / CRITICAL PATH INSTITUTE / /

Person

Michael Lawton / Denise Robinson Gravatt / Douglas Keller / Denise Robinson-Gravatt / Maria Teresa DeMagistris / John-Michael Sauer / Douglas Keller (Sanofi) / Frank Sistare / Thorsten Vetter / Michael Merz / /

Position

Academia External Contractors SMEs Collaborators Advisors / /

SocialTag